Current Assets
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value
Humana AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value increased by 212.7% to $7.29B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 30.3%, from $5.59B to $7.29B. Over 3 years (FY 2022 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value shows a downward trend with a -19.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2019
Last reportedQ1 2026
Metric ID:
afs_trading_securities_unrealized_loss_lt_12m_fvHistorical Data
13 periods
| Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.42B | $3.68B | $4.99B | $3.62B | $4.70B | $4.34B | $1.55B | $7.20B | $5.59B | $4.62B | $2.99B | $2.33B | $7.29B |
| QoQ Change | — | -16.7% | +35.6% | -27.4% | +29.9% | -7.7% | -64.3% | +364.7% | -22.3% | -17.5% | -35.3% | -22.0% | +212.7% |
| YoY Change | — | — | — | -18.1% | +27.8% | -13.0% | — | +98.8% | +18.9% | +6.4% | +92.9% | -67.6% | +30.3% |
Range$1.55B – $7.29B
CAGR+18.2%
Avg YoY Growth+19.6%
Median YoY Growth+18.9%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at Other Companies
Frequently Asked Questions
- What is Humana's afs and trading securities - unrealized loss position (<12 months) fair value?
- Humana (HUM) reported afs and trading securities - unrealized loss position (<12 months) fair value of $7.29B in Q1 2026.
- How has Humana's afs and trading securities - unrealized loss position (<12 months) fair value changed year-over-year?
- Humana's afs and trading securities - unrealized loss position (<12 months) fair value increased by 30.3% year-over-year, from $5.59B to $7.29B.
- What is the long-term trend for Humana's afs and trading securities - unrealized loss position (<12 months) fair value?
- Over 3 years (2022 to 2025), Humana's afs and trading securities - unrealized loss position (<12 months) fair value has grown at a -19.2% compound annual growth rate (CAGR), from $4.42B to $2.33B.